enow.com Web Search

  1. Ads

    related to: new treatment for migraine headaches medications approved by doctors

Search results

  1. Results from the WOW.Com Content Network
  2. This New Nasal Spray Could Provide Migraine Relief in ... - AOL

    www.aol.com/nasal-spray-could-migraine-relief...

    Zavzpret is a new nasal spray to treat migraine headaches in adults. But how does the medication work and who should try the new FDA-approved medication?

  3. FDA approves Pfizer's new nasal spray treatment for migraines

    www.aol.com/entertainment/fda-approves-pfizers...

    The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.

  4. A New Migraine Nasal Spray—Just Approved by the F.D.A ... - AOL

    www.aol.com/lifestyle/migraine-nasal-spray-just...

    For premium support please call: 800-290-4726 more ways to reach us

  5. Galcanezumab - Wikipedia

    en.wikipedia.org/wiki/Galcanezumab

    In September 2018, galcanezumab was approved in the United States for the preventive treatment of migraine in adults. [9] [10] The FDA granted the approval of Emgality to Eli Lilly. [9] [10] In November 2018, galcanezumab was approved for use in the European Union for the prophylaxis of migraine in adults who have at least four migraine days ...

  6. Ditan - Wikipedia

    en.wikipedia.org/wiki/Ditan

    Ditans are a class of abortive medication for the treatment of migraines. [1] The first ditan, Eli Lilly's lasmiditan, was approved by the FDA in 2019. Ditans selectively bind to the 5-HT 1F receptor subtype.

  7. Erenumab - Wikipedia

    en.wikipedia.org/wiki/Erenumab

    The results were measured as mean monthly migraine days in months 4, 5, and 6. At baseline the patients experienced between 4 and 14 migraine days per month with an average of 8.3. The medication significantly reduced the number of migraine days per month by 3.2 in the 70-mg group and 3.7 in the 140-mg group, versus 1.8 in the placebo (0-mg) group.

  1. Ads

    related to: new treatment for migraine headaches medications approved by doctors